Historical Valuation
LeMaitre Vascular Inc (LMAT) is now in the Undervalued zone, suggesting that its current forward PE ratio of 31.06 is considered Undervalued compared with the five-year average of 40.05. The fair price of LeMaitre Vascular Inc (LMAT) is between 112.03 to 134.13 according to relative valuation methord. Compared to the current price of 85.00 USD , LeMaitre Vascular Inc is Undervalued By 24.13%.
Relative Value
Fair Zone
112.03-134.13
Current Price：85.00
24.13%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
LeMaitre Vascular Inc (LMAT) has a current Price-to-Book (P/B) ratio of 4.80. Compared to its 3-year average P/B ratio of 5.24 , the current P/B ratio is approximately -8.47% higher. Relative to its 5-year average P/B ratio of 5.06, the current P/B ratio is about -5.12% higher. LeMaitre Vascular Inc (LMAT) has a Forward Free Cash Flow (FCF) yield of approximately 3.64%. Compared to its 3-year average FCF yield of 1.98%, the current FCF yield is approximately 84.32% lower. Relative to its 5-year average FCF yield of 2.41% , the current FCF yield is about 51.19% lower.
P/B
Median3y
5.24
Median5y
5.06
FCF Yield
Median3y
1.98
Median5y
2.41
Competitors Valuation Multiple
AI Analysis for LMAT
The average P/S ratio for LMAT competitors is 4.61, providing a benchmark for relative valuation. LeMaitre Vascular Inc Corp (LMAT.O) exhibits a P/S ratio of 6.87, which is 49.04% above the industry average. Given its robust revenue growth of 11.36%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for LMAT
1Y
3Y
5Y
Market capitalization of LMAT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of LMAT in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is LMAT currently overvalued or undervalued?
LeMaitre Vascular Inc (LMAT) is now in the Undervalued zone, suggesting that its current forward PE ratio of 31.06 is considered Undervalued compared with the five-year average of 40.05. The fair price of LeMaitre Vascular Inc (LMAT) is between 112.03 to 134.13 according to relative valuation methord. Compared to the current price of 85.00 USD , LeMaitre Vascular Inc is Undervalued By 24.13% .
What is LeMaitre Vascular Inc (LMAT) fair value?
LMAT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of LeMaitre Vascular Inc (LMAT) is between 112.03 to 134.13 according to relative valuation methord.
How does LMAT's valuation metrics compare to the industry average?
The average P/S ratio for LMAT's competitors is 4.61, providing a benchmark for relative valuation. LeMaitre Vascular Inc Corp (LMAT) exhibits a P/S ratio of 6.87, which is 49.04% above the industry average. Given its robust revenue growth of 11.36%, this premium appears unsustainable.
What is the current P/B ratio for LeMaitre Vascular Inc (LMAT) as of Jan 10 2026?
As of Jan 10 2026, LeMaitre Vascular Inc (LMAT) has a P/B ratio of 4.80. This indicates that the market values LMAT at 4.80 times its book value.
What is the current FCF Yield for LeMaitre Vascular Inc (LMAT) as of Jan 10 2026?
As of Jan 10 2026, LeMaitre Vascular Inc (LMAT) has a FCF Yield of 3.64%. This means that for every dollar of LeMaitre Vascular Inc’s market capitalization, the company generates 3.64 cents in free cash flow.
What is the current Forward P/E ratio for LeMaitre Vascular Inc (LMAT) as of Jan 10 2026?
As of Jan 10 2026, LeMaitre Vascular Inc (LMAT) has a Forward P/E ratio of 31.06. This means the market is willing to pay $31.06 for every dollar of LeMaitre Vascular Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for LeMaitre Vascular Inc (LMAT) as of Jan 10 2026?
As of Jan 10 2026, LeMaitre Vascular Inc (LMAT) has a Forward P/S ratio of 6.87. This means the market is valuing LMAT at $6.87 for every dollar of expected revenue over the next 12 months.